JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Support: [email protected]

Track Your Order

PPAR

B1943 Fenofibrate
1 Citation

Summary: PPARα agonist

insoluble in H2O; ≥12.75 mg/mL
A8957 AUDA

Summary: Potent epoxide hydrolase inhibitor/PPARα activator

Soluble in DMSO
A4324 Pioglitazone HCl

Summary: PPARγ agonist

insoluble in H2O; ≥19.65 mg/mL
A4310 Rosiglitazone HCl

Summary: PPARγ agonist

≥39.4 mg/mL
A4309 GW501516
1 Citation

Summary: PPARδ agonist,selective and potent

insoluble in H2O; ≥18.05 mg/mL
A4307 GW0742

Summary: PPARδ/β agonist,potent and selective

≥47.1 mg/mL
A4306 Ciprofibrate

Summary: PPARα agonist

insoluble in H2O; ≥10.85 mg/mL
A4305 WY-14643 (Pirinixic Acid)
7 Citation

Target: PPAR

Summary: PPARα agonist,selective and highly potent

insoluble in H2O; ≥16.2 mg/mL
A4304 Rosiglitazone

Summary: Potent PPARγ agonist

insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
A4303 GSK3787

Summary: PPARβ/δ antagonist,novel and irreversible

insoluble in H2O; ≥15.8 mg/mL